April 25, 2024

GlaxoSmithKline Biologicals SA et al v. Pfizer Inc. et al

Track this case

Case Number:

1:24-cv-00512

Court:

Delaware

Nature of Suit:

Patent

Judge:

Gregory B. Williams

Firms

Companies

Sectors & Industries:

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. June 16, 2026

    Judge Allows Pfizer, Moderna Defenses In GSK Vax IP Dispute

    A Delaware federal judge on Tuesday permitted Pfizer and Moderna to move ahead with their arguments that GlaxoSmithKline patents the company claims are infringed by the COVID-19 vaccines are unenforceable because of an unreasonable delay in obtaining them.

5 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS